Case Western Reserve, University Hospitals fundraising for adolescent, young adult cancer

June 30, 2014

Leaders from Case Western Reserve University and University Hospitals this evening announced a new collaborative fundraising effort focused on Adolescent and Young Adult (AYA) cancer. The news came as Chuck and Char Fowler announced their third major philanthropic commitment aimed at defeating the disease that claimed their 14-year-old daughter, Angie, in 1983.

Inspired by the new collaboration and the Fowlers' generosity, an anonymous donor also made a $5 million contribution to support the Angie Fowler Adolescent & Young Adult Cancer Institute at University Hospitals (UH) Rainbow Babies & Children's Hospital.

"Even as our nation has made immense strides in improving survival rates for pediatric and adult cancer patients, we have made far too little progress for teens and young adults," Case Western Reserve University President Barbara R. Snyder said. "Chuck and Char Fowler have helped bring unprecedented attention and resources to this critical need, and we feel privileged to build on their efforts with this new collaborative initiative."

Thomas F. Zenty III, chief executive officer of University Hospitals, noted that the funds for Angie's Institute are earmarked for completion of the Institute's 7th-floor inpatient area. The donor's gift is anticipated to inspire an additional $5 million in support from the philanthropic community by matching dollar for dollar gifts to Angie's Institute that range from $25,000 to $1 million.

"These gifts will amplify UH and CWRU as national leaders in treating and curing adolescent and young adult cancers," Zenty said. "This extraordinary philanthropic support for both research and clinical care promises to significantly advance treatments for our young cancer patients and AYA patients around the world."

The Fowlers' $6.7 million pledge to Case Western Reserve University will support an extraordinary array of state-of-the- art research initiatives designed to develop breakthrough solutions to treat and cure AYA cancers, the leading cause of disease-related death for this age group. Among other activities, the funds will accelerate development of medicines and therapies to stop the spread of tumors in adolescents and young adults; develop unique treatments to cure AYA cancers in a way that reduces chances of recurrence; and apply recent discoveries in MRI technology to the treatment of brain cancer in AYA patients. In addition, the effort also aims to bring increased focus to immunotherapy initiatives - that is, those that use the body's immune system to defeat cancer without the sometimes devastating toxicity involved in chemotherapy regimens.

Chuck and Char Fowler's first philanthropic commitment to defeating AYA cancer came in 2007, when they gave $1 million to UH Rainbow Babies & Children's Hospital to support the nation's first-ever chair in AYA cancer. With an additional $500,000 from the Rainbow Babies & Children's Foundation, the hospital created the position and named pediatric oncologist Joe Matloub, MD, as the inaugural Angie Fowler Chair in Adolescent & Young Adult Cancer Research.

Four years later, Chuck and Char Fowler were joined by their daughters and sons-in-law, Chann and Ed Spellman and Holley and Rob Martens, in making a $17 million commitment to create the Angie Fowler Adolescent & Young Adult Cancer Institute at University Hospitals (UH) Rainbow Babies & Children's Hospital.

Angie's Institute, - fully integrated with University Hospitals Seidman Cancer Center and Case Comprehensive Cancer Center - features a dedicated outpatient treatment facility, which opened this spring. The newly renovated space is one of the first in the country to offer separate, age-appropriate areas, technologies and amenities for babies/children and adolescents/young adults. In addition, it also includes the soon-to-be-constructed expanded inpatient unit for pediatric and young adult patients, which will feature all private rooms with sleeping accommodations for parents, along with a rooftop garden at UH Rainbow Babies & Children's Hospital.

The Fowlers' newest commitment represents the first-ever creation of a center focused on AYA cancer within a Comprehensive Cancer Center, a designation the National Cancer Institute has given to just 41 centers across the U.S. The Case Comprehensive Cancer Center - a collaboration among Case Western Reserve, Cleveland Clinic and University Hospitals Seidman Cancer Center - involves 350 scientists and physicians dedicated to understanding how to prevent, treat, and cure all forms of the disease. The Center today has nine areas of focus, among them Genetics and Personalized Medicine, Prostate and Kidney Cancers, and Breast Cancer. The Fowlers' investment will advance efforts to make AYA Cancer another priority, both because of the region's existing strengths in the area and the overwhelming need for additional efforts.

The National Cancer Institute reports that AYA cancer survival rates have remained stagnant since 1975 for a range of reasons, among them a lack of awareness among both young people and physicians. When high school student Steven Giallourakis found his back and legs starting to feel tight while playing basketball, both he and his doctors presumed the issue was muscular and referred him to physical therapy. It wasn't until Steve began having trouble even lying on his back that doctors probed for another cause - and found a softball-sized tumor near his spine.

"Who thinks a 15 year-old has cancer?" said Giallourakis, now 23 after twice triumphing over cancer as well as complications that included a snapped titanium rod in his back and graft-versus-host disease. A finance major at Cleveland State University, he recently became the Ohio representative for the national nonprofit, Teen Cancer America. He is driven to raise awareness and advocate for approaches that combine attention to patients' psychological experiences and the need for approaches that address their unique stage of life. At the same time, he appreciates the vital place of pure science.

"You want to find a cure," he said. "You want to prevent it. You can't do that without the research... Everything has to go together."

John J. Letterio, MD, a Professor of Pediatrics at Case Western Reserve and Chief of the Division of Pediatric Hematology/Oncology at UH Rainbow Babies & Children's Hospital, made AYA cancer a primary focus when he came to Cleveland from the National Cancer Institute in 2006. Over time, the ranks of faculty and physicians whose work applies to AYA cancers has grown steadily, along with a powerful appreciation of the possibilities inherent in interdisciplinary collaboration.

"Our job ultimately is to advocate, to take on the biggest challenges," said Letterio, also a member of the Case Comprehensive Cancer Center. "This [AYA cancers] is a place where we could make a real difference."

Additional causes of stagnant survival rates include lack of health insurance among this age group, extremely low rates of participation in clinical trials that test the safety and effectiveness of emerging treatments, and biological differences in the way cancers affect adolescent and young adult patients. New insights available through genomics and imaging, however, offer the promise of ever-more accurate understanding of precisely how certain cancers affect AYA patients - and, in turn, more precise approaches to defeating them.

Researchers and physicians from the Case Comprehensive Cancer Center described some of these advances at an event that followed the announcement of the Fowlers' pledge and anonymous donor's challenge grant.

"We are the pacesetters for what's happening in this realm," Letterio said.
-end-
About Case Western Reserve University School of Medicine

Founded in 1843, Case Western Reserve University School of Medicine is the largest medical research institution in Ohio and is among the nation's top medical schools for research funding from the National Institutes of Health. The School of Medicine is recognized throughout the international medical community for outstanding achievements in teaching. The School's innovative and pioneering Western Reserve2 curriculum interweaves four themes--research and scholarship, clinical mastery, leadership, and civic professionalism--to prepare students for the practice of evidence-based medicine in the rapidly changing health care environment of the 21st century. Nine Nobel Laureates have been affiliated with the School of Medicine.

Annually, the School of Medicine trains more than 800 MD and MD/PhD students and ranks in the top 25 among U.S. research- oriented medical schools as designated by U.S. News & World Report's "Guide to Graduate Education."

The School of Medicine's primary affiliate is University Hospitals Case Medical Center and is additionally affiliated with MetroHealth Medical Center, the Louis Stokes Cleveland Department of Veterans Affairs Medical Center, and the Cleveland Clinic, with which it established the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University in 2002. http://casemed.case.edu

About University Hospitals Rainbow Babies & Children's Hospital

Located on the campus of University Hospitals Case Medical Center in Cleveland, Ohio, University Hospitals Rainbow Babies & Children's Hospital is a 244-bed, full-service pediatric hospital and academic medical center, solely dedicated to the health care needs of children. A trusted leader in children's health care for more than 125 years, UH Rainbow Babies & Children's Hospital consistently ranks among the top children's hospitals in the nation. As the region's premier resource for pediatric referrals, UH Rainbow Babies & Children's Hospital's dedicated team of more than 1,300 pediatric specialists uses the most advanced treatments and latest innovations to deliver the complete range of pediatric specialty services to approximately 9,000 inpatients and 550,000 outpatients each year. Learn more at http://www.RainbowBabies.org

Case Western Reserve University

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.